9th Circuit Allows Appeal Of RICO TPP Class Certification For Actos Cancer Risk

(August 25, 2023, 1:52 PM EDT) -- LOS ANGELES — The Ninth Circuit U.S. Court of Appeals granted a petition by two pharmaceutical companies for permission to appeal a decision by a district court to certify a national third-party payer (TPP) class of entities that paid for the diabetes drug Actos XE "Actos" ....

Attached Documents

Related Sections